Current and future management of EGFR-positive NSCLC - European Medical Journal

Current and future management of EGFR-positive NSCLC

Oncology

With: Dr. Sackier (Moderator), Dr. Moreno (KOL) and Prof. Vansteenkiste (KOL)

Job bag: CP-329213

Date of prep: July 2022

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content of the webinar has not been approved for distribution to United Kingdom (UK) healthcare professionals.

 

 

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now